Although several reports have suggested that flumazenil has intrinsic actions, such as reversing hepatic coma and increasing anxiety [7, 8], their mechanisms are unlikely to be mediated by decreased EAAT3 activity. The gene discussed is SLC1A1; the disease is Anxiety.